Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 64 NETWORK 29 NIH 19 INDUSTRY 8 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Thoracic 1 Sarcoma 1

Conditions

Interventions

Doxorubicin 3 High-Throughput Nucleotide Sequencing 2 Base Sequence 2 trametinib 1 spartalizumab 1 ribociclib 1 pembrolizumab 1 palbociclib 1 olaparib 1 nilotinib 1 ipatasertib 1 glasdegib 1 futibatinib 1 durvalumab 1 dactolisib 1 dabrafenib 1 ceritinib 1 capmatinib 1 camrelizumab 1 apatinib 1 anlotinib 1 Zoledronic Acid 1 Valganciclovir 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Rituximab 1 Radiotherapy 1 Psychoanalysis 1 Nivolumab 1 Lapatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Ifosfamide × Sarcoma × Clear all

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡